Answers are grounded in this paper and cite their sources.
For the bacterial case, this paper evaluates the active-site description pushed to the warmest freezing known, where ice-nucleating proteins from a plant-associated bacterium organise water so effectively that droplets freeze several degrees below the melting point, and the site spectrum falls steeply as temperature rises toward zero. The case examined is a preparation of the commercial bacterial nucleant derived from Pseudomonas syringae, of the kind used in droplet freezing assays and snowmaking, evaluated at minus seven degrees Celsius with a site density of 4e10 per square metre of nucleant surface at that temperature, a steep slope of 0.9 decades per kelvin, fifty square micrometres of nucleant surface per assay droplet, an airborne biological surface area of 2.5e-11 square metres per litre of air, a contact angle taken as thirty-five degrees and an interfacial energy of 0.033 joules a square metre. The quantities produced are the expected active sites per droplet at minus seven degrees, the frozen fraction of an assay at that temperature, the airborne concentration implied by a modest biological loading, and the penalty exacted by one kelvin of warming. Site density 40,000,000,000 per m2 drives the bacterial case: 2 sites per assay droplet for the bacterial case, 0.865 of the assay of the bacterial case frozen, and 1 particles per litre airborne for the bacterial case. Nothing else in the atmosphere freezes water this warm in quantity; the numbers show both the power of the protein and the narrowness of its ledge.
No takes yet. Share an insight, caveat, or question.
William Alexander Aldred (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: